15:07 CEST Morrow Bank ASA - The Norwegian FSA has granted necessary approval for the merger and redomicilation process on plan ...

04 Jul 2025 19:00 CEST RIBER: Bilan semestriel du contrat de liquidité contracté avec la Société de Bourse Gilbert Dupont 04 Jul 2025 18:42 CEST ABIONYX Pharma : Information relative au nombre total ...

12-month readout of the HeROPA phase 2b clinical trial shows potential through key secondary endpoint PGA 0/1, where the per protocol population approaches significance (p = 0.07) after one year of ...

Ageas kondigde vandaag aan dat alle noodzakelijke goedkeuringen van toezichthouders voor de overname van Acromas Insurance Company Limited (AICL), de underwriting-activiteiten van Saga, zijn verkregen ...

Bergen, Norway and Oslo, Norway, 30 June 2025 - BerGenBio ASA (OSE: BGBIO) ("BerGenBio" or the "Company") and Oncoinvent ASA (OSE: ONCIN) ("Oncoinvent") announce that they have entered into a merger ...

USEFUL LINKS - Download ESG Bonds list - More on ESG Bonds Issuer or ISIN Location Type Issuer ISIN Listing date Nom. (mm) CCY Type Venue Å Energi AS NO0013530543 04/11/2025 500,00 NOK Green Bond Oslo ...

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA OR JAPAN OR ANY ...

In collaboration with key market players. As part of this initiative, Euronext has been organising a series of informative webinars, featuring expert speakers from the industry. These webinars cover a ...

Asker, 1 July 2025: Reference is made to the stock exchange releases from Argeo ASA ("Argeo") published on 24 January 2025 and 31 March 2025. Argeo is pleased to announce that it, together with its ...

Reference is made to stock exchange notice of 1 March 2024, where Endúr ASA (“The Company”) announced its plan to buy up to 1,629,741 own shares for a total maximum NOK 50 million. In week 26 2025, ...

Hamilton, Bermuda, July 1, 2025 -- Golar LNG Limited (the “Company”) (NASDAQ: GLNG) announced today the closing of its previously announced offering of 2.75% Convertible Senior Notes due 2030 (the ...

GenSight Biologics (the " Company ") (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal ...